| 11/05/2026 7:35 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 10/30/2026 7:49 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/26/2026 3:00 PM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 10/26/2026 5:41 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/01/2026 11:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/17/2026 5:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/25/2026 5:06 AM | Sanofi (1121404) Filer | Form N-PX Annual Report of Proxy Voting Record of Registered Management Investment Company | |
| 08/12/2026 7:09 AM | Latigo Biotherapeutics, Inc. (2056611) Issuer Sanofi (1121404) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/12/2026 7:18 AM | Latigo Biotherapeutics, Inc. (2056611) Issuer Sanofi (1121404) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 2:45 PM | Attovia Therapeutics, Inc. (2058707) Issuer Sanofi (1121404) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for SNY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/30/2026 6:34 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/30/2026 5:28 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/22/2026 8:50 AM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 07/17/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/07/2026 8:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/30/2026 12:27 PM | Sanofi (1121404) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/30/2026 11:54 AM | Sanofi (1121404) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/30/2026 10:45 AM | Sanofi (1121404) Filer | Form NT 11-K | |
| 06/30/2026 10:49 AM | Sanofi (1121404) Filer | Form NT 11-K | |
| 06/24/2026 7:43 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/22/2026 7:43 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/12/2026 10:41 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/08/2026 5:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/28/2026 5:06 AM | Sanofi (1121404) Filer | Form SD Specialized Disclosure Report | |
| 05/27/2026 9:31 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/07/2026 7:47 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 05/06/2026 5:00 AM | Agomab Therapeutics NV (2020932) Subject Sanofi (1121404) Filed by | Form SCHEDULE 13G | |
| 05/05/2026 5:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/29/2026 5:04 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/27/2026 11:58 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/23/2026 6:20 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2026 5:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/10/2026 8:58 AM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 03/31/2026 11:19 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/24/2026 10:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/10/2026 9:40 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/04/2026 11:26 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/03/2026 5:15 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/23/2026 8:19 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/17/2026 12:28 PM | Sanofi (1121404) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
I'm handing you this one free (Ad) Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company.
That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th. See today's free stock pick before the December 8th deadline here |
| 02/17/2026 11:34 AM | Sanofi (1121404) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 02/17/2026 11:44 AM | Sanofi (1121404) Filer | Form IRANNOTICE | |
| 02/17/2026 8:33 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/12/2026 8:17 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/11/2026 7:47 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 02/10/2026 8:18 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/10/2026 5:06 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 02/06/2026 9:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/05/2026 5:17 AM | Sanofi (1121404) Filer | Form S-8 POS | |
| 01/30/2026 6:55 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 01/29/2026 7:56 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/28/2026 5:37 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 01/23/2026 8:58 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/16/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/12/2026 5:11 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T | |
| 01/09/2026 5:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 3:42 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 3:44 PM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-C | |
| 12/29/2025 5:22 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 5:23 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/23/2025 8:52 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/22/2025 11:25 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/15/2025 9:17 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/12/2025 11:26 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/03/2025 10:30 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 11:29 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |